Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience.
about
Risk based neoadjuvant chemotherapy in muscle invasive bladder cancerStandard cystectomy fits all: truth or myth?Muscle-invasive urothelial bladder cancer: an update on systemic therapyMultimodal management of muscle-invasive bladder cancerSystemic, perioperative management of muscle-invasive bladder cancer and future horizons.Systemic therapy for bladder cancer finally comes into a new age.Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data Base.Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studiesNeoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity.Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists.Bladder cancer in the elderly.Exploring the burden of inpatient readmissions after major cancer surgery.The effect of age and gender on bladder cancer: a critical review of the literatureMaximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy.Perioperative morbidity of radical cystectomy: A reviewEvaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer.Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy.Preoperative hypoalbuminemia is a risk factor for 30-day morbidity after gynecological malignancy surgeryImmediate Radical Cystectomy for Massive Bleeding of Bladder CancerPractical use of perioperative chemotherapy for muscle-invasive bladder cancer: summary of session at the Society of Urologic Oncology annual meeting.Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion.Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy.Multimodal therapies for muscle-invasive urothelial carcinoma of the bladderBenefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy.Alvimopan in an Enhanced Recovery Program Following Radical CystectomyThe role of chemotherapy in upper tract urothelial carcinoma.Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral ProcessNeoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer.The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder CancerThe July Effect in Radical Cystectomy: Mortality, Morbidity, and Efficiency.Neoadjuvant therapy preceding prostatectomy for prostate cancer: rationale and current trials.Bladder tumours: time for a paradigm shift?Urothelial carcinoma of the bladder: definition, treatment and future efforts.Neoadjuvant chemotherapy for invasive bladder cancer.Minimally invasive cystectomy approaches in the treatment of bladder cancer.Trimodality therapy for bladder conservation in treatment of invasive bladder cancer.Primary bladder preservation treatment for urothelial bladder cancer.Clavien classification in urology: Is there concordance among post-graduate trainees and attending urologists?Open radical cystectomy: still the gold standard for muscle invasive bladder cancer.Impact of Location of Readmission on Outcomes After Major Cancer Surgery.
P2860
Q26773664-811F9261-BF06-4A3D-815C-684A714F3B24Q26774347-D7D43815-EF60-4F66-9C79-7AADB98D561CQ26775780-CA4ACA5D-6B79-4281-BDEF-B11A2DA45409Q27011624-398842BC-D1E6-4A99-8C61-F1ABB1F6C39AQ30240816-FE3A5C2C-E2C8-40D9-8D41-990E2C489EEAQ30249047-99D63E00-9655-493B-B992-21FFE08DD581Q33605299-2ECD6BF6-CA37-469E-BBC3-967A221DBFBFQ33623496-108A4467-67B3-41D0-A563-DC3C798B2F32Q33662842-9CF7CA82-ED97-4D8C-88F5-748D6619C204Q34435978-26965DAF-6462-44E9-9FC1-E5E49D62E951Q34479053-5E7C5061-E3AA-4ED5-8948-F4BA242A4E88Q35040688-1779ABAD-77E9-409D-87D8-4AD84033BF0DQ35043055-B92FBF7C-21B1-44E0-A853-BDC59B640A85Q35109085-04AA0ECC-0737-4F81-9BE1-B36F7DD42B18Q35125738-2D9D1CD4-AE4C-4932-B3AA-930F2A90D2E0Q35354332-F3FCCB3F-E9DA-4ABF-A8FC-292AF5704CF0Q35869334-B1B087A0-2012-4BB1-B3FB-A10DCA093598Q36107574-9F3F7244-75A6-4474-B7AA-A70F08CD4D23Q36446891-B66054BD-ABB8-4DA2-BBBE-ACE8F56ECD0AQ36474159-87D09FE0-2045-4195-8F42-226A6DFC163DQ36628852-3ECA3974-85CD-40C7-81BA-5FD574D156DDQ36962466-D7C8B5B5-8185-498E-8C6B-03F9A6376606Q36973553-EF905BA0-B7FC-4FC5-9E85-A66B680CC72FQ37053991-328B0892-A73B-41A6-BEC3-B41FE05ADC3FQ37057032-D9EF8F43-408A-4297-A3BE-83855945790BQ37071515-8E9C04C7-85F6-4649-B702-DE9F66F997F9Q37371642-123F97CB-A095-4B2C-88AD-A3278429A242Q37508037-BAB3EE4D-5974-4007-837E-020CA384E1AFQ37530349-507FDB96-2088-4F6E-B395-ABBEBA22AF5AQ37530382-42F803B4-65A8-40E7-A4CD-A597C67404CBQ37705424-9E3562F1-3537-47D2-9137-C89FFBD7387CQ37868801-58AC2D28-06E4-4FA3-9198-D16840E4FFABQ37944437-700BE526-6012-4733-BDDD-4B228E8038FDQ37982318-EC0A2D49-F9EA-471F-A403-CC9521DE6AC3Q38020239-EDD44ECC-EA64-4BE1-AB46-6C6BFD263859Q38076093-355A6F2D-C565-488A-942C-A70EA000C915Q38118058-81DE577B-09A3-43D5-A177-E400827AE266Q38119226-91BE83C3-D717-4623-AFB0-5293201CA372Q38639574-6F368601-0CA6-4E5F-B6FC-3C8B26F053CAQ38822689-6F26B5E9-B08B-4D25-A2A0-3617FC816A98
P2860
Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potential impact of postoperat ...... iary cancer center experience.
@en
Potential impact of postoperat ...... iary cancer center experience.
@nl
type
label
Potential impact of postoperat ...... iary cancer center experience.
@en
Potential impact of postoperat ...... iary cancer center experience.
@nl
prefLabel
Potential impact of postoperat ...... iary cancer center experience.
@en
Potential impact of postoperat ...... iary cancer center experience.
@nl
P2093
P50
P1433
P1476
Potential impact of postoperat ...... tiary cancer center experience
@en
P2093
Ahmad Shabsigh
Angel M Cronin
Caroline Savage
Harry W Herr
Matthew I Milowsky
P304
P356
10.1016/J.EURURO.2008.07.018
P407
P577
2008-07-14T00:00:00Z